Dan Groman - Jul 17, 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role: Chief Technology Officer
Signature: /s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol: ENFN
Transactions as of: Jul 17, 2023
Transactions value $: -$43,849
Form type: 4
Date filed: 7/19/2023, 04:15 PM
Previous filing: Jun 22, 2023
Next filing: Aug 10, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Ownership	Footnotes
transaction	ENFN	Class A Common Stock	Sale	-$43.8 K	-3.88 K	-3.44%	$11.31	109 K	Jul 17, 2023	Direct	F1

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2022.